Blog
RSS FeedPosted by Michael Wonder on 02 Dec 2017
Public Summary Documents - August 2017 PBAC meeting
1 December 2017 - The public summary document for etanercept from the August 2017 PBAC meeting is now available. ...
Posted by Michael Wonder on 02 Dec 2017
Accelerated access to new drugs and technologies
22 November 2017 - UK government’s proposed scheme is unlikely to improve patient outcomes. ...
Posted by Michael Wonder on 01 Dec 2017
Continuing to make new medicines affordable for Australians
1 December 2017 - A new medicine to treat soft tissue sarcoma will be available through the Pharmaceutical Benefits Scheme, giving ...
Posted by Michael Wonder on 30 Nov 2017
Schedule of Pharmaceutical Benefits - 1 December 2017 update
1 December 2017 - The December 2017 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Nov 2017
New Zealand Pharmaceutical Schedule - 1 December 2017
1 December 2017 - The December 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Nov 2017
New report reveals need for a gender-based approach to health funding for women to have full economic empowerment
30 November 2017 - Recent CADTH recommendation to improve access to oral uterine fibroids treatment presents positive step forward in helping ...
Posted by Michael Wonder on 30 Nov 2017
Reducing the waste in the massive health care system
30 November 2017 - Lorica Health's CEO Paul Nicolarakis says the health analytics company is helping the industry and government ...
Posted by Michael Wonder on 30 Nov 2017
Prioritise investment in the PBS to improve access to all cancer medicines
30 November 2017 - Medicines Australia response to the Senate Select Committee report “Funding for Research into Cancers with Low ...
Posted by Michael Wonder on 30 Nov 2017
Which biosimilar medicines are available in Australia?
30 November 2017 - Information is available on the Department of Health website setting out the biosimilar brands of medicines which ...
Posted by Michael Wonder on 29 Nov 2017
Multiple sclerosis sufferer Natalie Adams lives in fear
29 November 2017 - Lying in a hospital bed with her skin feeling like it had been dipped in acid, ...
Posted by Michael Wonder on 29 Nov 2017
Auckland mum is having to self-fund drugs to extend her life
28 November 2017 - All Megan Casey wants to do is see her children get married and be a grandmother. ...
Posted by Michael Wonder on 29 Nov 2017
Over-reliance in cardiovascular treatment – a supply risk that needs to change
29 November 2017 - New Zealand’s reliance on the cardiovascular medicines metoprolol succinate and cilazapril is out of step with ...
Posted by Michael Wonder on 27 Nov 2017
NICE no for Halaven in new indication
27 November 2017 - A lack of clinical evidence proving its effectiveness has led NICE to publish draft guidance refusing ...
Posted by Michael Wonder on 27 Nov 2017
Revised process for filing CDR submissions and resubmissions
27 November 2017 - The CADTH Common Drug Review is aligning the process for secure file sharing with the pan-Canadian ...
Posted by Michael Wonder on 27 Nov 2017
Kidney disease drug recommended by NICE 'may do more harm than good
24 November 2017 - Little evidence that phosphate binders improve patient wellbeing, warn experts, while one type may contribute to increased ...